PRICE T ROWE ASSOCIATES INC /MD/ - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$244
-0.4%
36,531
+35.4%
0.00%
Q2 2023$245
-8.6%
26,973
-26.7%
0.00%
Q1 2023$268
-6.0%
36,793
-5.8%
0.00%
Q4 2022$285
-99.9%
39,055
-21.9%
0.00%
Q3 2022$387,00049,9750.00%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,383,029$24,594,6214.83%
Velan Capital Investment Management LP 494,136$3,592,3693.06%
BVF INC/IL 10,563,748$76,798,4482.81%
JOHNSON & JOHNSON 1,000,000$7,270,0002.36%
SPHERA FUNDS MANAGEMENT LTD. 952,642$6,925,7071.16%
PFM Health Sciences, LP 3,204,790$23,298,8231.03%
Pier Capital, LLC 862,736$6,272,0910.95%
Boxer Capital, LLC 2,500,000$18,1750.89%
Deep Track Capital, LP 2,345,073$17,048,6810.70%
SILVERARC CAPITAL MANAGEMENT, LLC 198,477$1,442,9280.60%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders